Keyphrases
Mouse Model
100%
Therapeutic Intervention
100%
Sickle Cell Disease
100%
Repurposing
100%
Cell-cell Interaction
100%
Pyridoxamine
100%
Neutrophils
77%
Platelets
33%
Tumor Necrosis Factor-α
22%
Endothelial Cells
22%
Vascular Endothelium
22%
Hydroxyurea
22%
Microvessels
22%
Cell Aggregation
22%
Novel Therapeutics
11%
Oral Administration
11%
Integrin
11%
Dose Effect
11%
Ex Vivo Studies
11%
Inhibitory Effect
11%
Neutrophil Adhesion
11%
Occlusion
11%
Therapeutic Agents
11%
Vaso-occlusion
11%
Vitamin B6
11%
Activation State
11%
Intercellular Adhesion molecule-1 (ICAM-1)
11%
E-selectin
11%
Intravital Microscopy
11%
Adhesive Behavior
11%
Platelet-leukocyte Aggregates
11%
Short-term Treatment
11%
Co-treatment
11%
Oral Treatment
11%
Hypoxia-reoxygenation
11%
Cremaster
11%
Medicine and Dentistry
Sickle-Cell Disease
100%
Cell Interaction
100%
Pyridoxamine
100%
Neutrophil
100%
Platelet
44%
Tumor Necrosis Factor
22%
Endothelial Cell
22%
Microvessel
22%
Vascular Endothelium
22%
Hydroxyurea
22%
Cell Aggregation
22%
Ex Vivo
11%
Oral Drug Administration
11%
Adhesive Agent
11%
Therapeutic Agent
11%
Hypoxia
11%
Intravital Microscopy
11%
Intercellular Adhesion Molecule 1
11%
Endothelial Leukocyte Adhesion Molecule 1
11%
Pyridoxine
11%
Short Course Therapy
11%
Integrin
11%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse Model
100%
Repurposing
100%
Sickle Cell Anemia
100%
Pyridoxamine
100%
SAD Mouse
62%
Tumor Necrosis Factor
25%
Hydroxycarbamide
25%
Integrin
12%
Hypoxia
12%
Adhesive Agent
12%
Intercellular Adhesion Molecule 1
12%
E-Selectin
12%
Intravital Microscopy
12%
Pyridoxine
12%